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Abstract 36 
Ageing is associated with re-modelling of the immune system to enable the maintenance of 37 
life-long immunity. In the CD8+ T cell compartment, ageing results in the expansion of highly-38 
differentiated cells that exhibit characteristics of cellular senescence. Here we found that 39 
CD27-CD28-CD8+ T lost the signalling activity of the T cell antigen receptor (TCR) and 40 
expressed a protein complex containing the agonistic NK receptor NKG2D and the NK 41 
adaptor molecule DAP12, which promoted cytotoxicity against cells that expressed NKG2D 42 
ligands. Immunoprecipitation and imaging cytometry indicated that the NKG2D-DAP12 43 
complex was associated with sestrin 2 (Sesn2). The genetic inhibition of Sesn2 resulted in 44 
decreased expression of NKG2D and DAP12 and restored TCR signaling in senescent-like 45 
CD27-CD28-CD8+ T cells. Therefore, during ageing, sestrins induces the reprogramming of 46 
non-proliferative senescent-like CD27-CD28-CD8+ T cells to acquire a broad-spectrum, 47 
innate-like killing activity.  48 
  49 
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Introduction 50 
Immunity declines during ageing and this is associated an increased incidence of infections 51 
and malignancy1. It is therefore essential to understand mechanisms that contribute to 52 
altered immunity in older individuals in order to identify possible therapeutic targets. Because 53 
the thymus involutes from puberty onwards, its contribution to the maintenance of the T cell 54 
pool decreases considerably during ageing. Instead, antigen specific T cells are maintained 55 
in older individuals by repeated episodes of activation and proliferation triggered by specific 56 
or cross-reactive antigenic challenge or by homeostatic cytokines2. This extensive 57 
proliferative activity leads ultimately to extreme functional differentiation and the 58 
development of T cell senescence associated with telomere erosion, decreased signalling 59 
through the T cell antigen receptor (TCR), activation of the telomere-extending enzyme 60 
telomerase and also growth arrest3-5. Because the replicative activity of T cells is impaired as 61 
senescence develops, mechanisms other that T cell proliferation may be required to 62 
maintain optimal immune protection during ageing.  63 
Highly-differentiated CD8+ T cells that lose expression of the surface receptors CD28 and 64 
CD27 (CD27-CD28-) exhibit senescent-like characteristics that include low proliferative 65 
activity, short telomeres, low telomerase activity and expression of senescence-associated 66 
cell surface (CD57 and KLRG1) and intracellular (the MAP kinase p38, γH2AX) molecules4. 67 
CD27-CD28-CD8+ T cells also upregulate receptors associated with natural killer (NK) cells, 68 
such as inhibitory (KLRG1, NKG2A) and activatory proteins (NKG2C and NKG2D)6. Whether 69 
the acquisition of the senescence-like characteristics and the expression of NK receptors 70 
(NKR) are linked or are controlled independently remains unclear. 71 
Sestrins are stress-sensing proteins, induced by conditions of low glucose or oxidative stress 72 
or cellular senescence, that inhibit TCR activation and CD4+ T cell proliferation in both mice 73 
and humans7. Here we showed that sestrins inhibited the expression of the TCR signaling 74 
molecules LAT, ZAP70 and LCK in mouse and human CD8+ T cells, and concomitantly 75 
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induced the expression of both inhibitory and activatory NKRs. Furthermore, sestrins 76 
regulated the association of NKG2D with the scaffold protein DAP12, which converts it into 77 
an activating receptor that can trigger the secretion of cytokines and cytotoxicity towards 78 
target cells bearing NKG2D ligands, independently of the TCR. Collectively, these data 79 
indicate that senescent-like CD8+ T cells are not a defective end-stage population. Instead 80 
these cells while non-proliferative, are instead re-programmed during differentiation to 81 
recognize and kill via both TCR8 as well as NKR recognition mechanisms, a process 82 
regulated by the sestrins. The repurposing of senescent-like CD8+ T cells to mediate innate-83 
like functional activity may be crucial to mitigate against the increased burden of tumours 84 
and stromal senescent cells that accumulate in tissues during ageing9,10. 85 
 86 
Results 87 
Human CD8+ TEMRA cells upregulate NKRs and adapters but decrease TCR 88 
components  89 
First, we isolated peripheral blood CD8+ T cell subsets from six healthy donors and 90 
compared transcriptomes using Affymetrix U133 plus 2 microarrays of CD27+CD45RA-CD8+ 91 
central memory T (TCM) cells, CD27-CD45RA- CD8+ effector memory T (TEM) cells and CD27-92 
CD45RA+CD8+ terminal effector memory T (TEMRA) cells relative to the CD27+CD45RA+CD8+ 93 
naïve T (TN) cells (Fig. 1a and Extended Data Fig. 1a). Differentially expressed genes in 94 
these CD8+ T cell subsets were identified based on a minimum of a 2-fold change (p <0.05, 95 
false-discovery rate (FDR) for multiple comparisons <0.05% (Supplementary table 1). 96 
Hierarchical clustering of genes associated with effector cell function indicated a 97 
transcriptional signature that distinguished TEMRA cells from TN cells (Fig. 1b,c). Genes 98 
involved in co-stimulation (Cd28, Cd27), TCR signaling (Trac, Cd3e, Cd3g, Lck, Lat, Plcg1) 99 
and proliferation and cell cycle control (Ccne1, Ccnd3) were downregulated in TEMRA 100 
compared to TN (Fig. 1b,c). Compared to CD8+ TN cells, CD8+ TEMRA cells upregulated genes 101 
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encoding the transcription factors Zeb2 (fold change: 10.75, p < 0.0001) and Zbtb16 102 
(encoding PLZF, fold change: 6.48, p < 0.0001, Fig. 1b, Supplementary table 2) which are 103 
known to regulate terminal differentiation of memory T cells11 and the development of innate-104 
like features in T cells in mice12,13. Zbtb16 was also increased in TCM and TEM compared to TN 105 
cells (7.7- and 4.8-fold respectively; Supplementary table 2). TEMRA cells upregulated genes 106 
encoding NKRs (including Kir family members, Nkg2a/c, and Klrg1), innate signalling 107 
adaptors (Tyrobp, encoding DAP12) and molecules involved in cytotoxicity (Gzma/b, Prf, 108 
Fasl, Itgav and Itgb1)14. TEMRA cells also upregulated chemokine receptors associated with 109 
the migration of NK cells into tissues (Cx3cr1, S1pr5, and Cmklr1)15, indicating that the 110 
differentiation of CD8+ T cells from TN into TEMRA was associated with a transcriptional 111 
program that promoted cytotoxic effector functions at the expense of proliferative potential 112 
and suggested that highly differentiated CD8+ T cells may express effector functions 113 
independent of the TCR. 114 
Flow cytometric analysis indicated that the expression of NKRs (listed below) on non-NK 115 
cells was elevated on CD3+CD27-CD45RA+CD8+ TEMRA cells (Fig. 1d, Extended Data 1a) in 116 
PBMCs isolated from a separate cohort of healthy donors (n = 22; median age = 52; range = 117 
25-83). The repertoire of NKRs expressed on CD8+ TEMRA cells was diverse and included 118 
both activating (NKG2D, NKG2C and KIR2DS) and inhibitory (NKG2A, KIR2DL/KIR3DL and 119 
CD244) receptors, as well as the maturation markers KLRG1 and CD57 (Fig. 1D, Extended 120 
Data 1b). Expression of CD28 and CD27 is sequentially lost on CD8+ T cells as they 121 
transition from CD27+CD28+ CD8+ TN cells to CD27+CD28- intermediate CD8+ T cells and to 122 
terminal, or senescent-like, CD27-CD28- CD8+ T cells16,17.  To analyse the expression of the 123 
TCR signalling machinery in CD8+ TEMRA cells, we isolated CD8+ T cell subsets by their 124 
relative expression of CD27 and CD28, as the use of CD27 and CD28 as markers enabled 125 
the isolation of more cells for functional analyses. The CD27-CD28-CD8+ T cell subset 126 
contained the TEMRA subset and TEM (Extended Data 1c) and had increased expression of 127 
NKRs compared to CD27+CD28+CD8+ TN cells (Extended Data 2a). Senescent-like CD8+ T 128 
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cells, either identified as CD27-CD28-18,19 or as CD27-CD45RA+20 increase in both number 129 
and proportion during ageing and exhibit markers of senescence4,5,7,20. Immunoblots showed 130 
a significant downregulation of LCK, LAT and PLCγ1, but upregulation of Zap70 in CD27-131 
CD28-CD8+ T cells compared to CD8+ TN cells (Fig. 1e). CD27-CD28-CD4+ T cells also 132 
acquired cell-surface expression of NKRs (including KLRG1, NKG2C and NKG2D), but to a 133 
lower degree than CD27-CD28-CD8+ T cells (Extended Data 2b). Together, these findings 134 
indicate the increased expression of NKRs on CD8+ T cells with characteristics of terminal 135 
differentiation and senescence. 136 
Individual TEMRA CD8+ T cells are senescent, and express NKRs and cytotoxic 137 
machinery 138 
To investigate whether the NKRs, the cytotoxicity-related molecules and the senescence 139 
markers were expressed on individual CD8+ TEMRA cells, we used single cell RNA-140 
sequencing (scRNA-seq) to investigate the transcriptomes of ~62,000 CD8+ T cells isolated 141 
from six healthy old donors. CD8+IL-7R+ and CD8+IL-7R- T cells were FAC-sorted from each 142 
donor resulting in 12 samples (Extended data 3a). Sorts yielded an average of 6199 143 
CD8+IL-7R+ cells (SD 1582) and 4192 CD8+IL-7R- cells (SD 1269) per donor, with an 144 
average of 1043 and 1011 genes per cell, respectively (Extended data 3b,c). After 145 
discarding hybrid transcriptomes (multiplets) using Scrublet (Methods), raw data from the 12 146 
samples (six CD8+IL-7R+ and six CD8+IL-7R- T cells) were combined. scRNA-seq profiles 147 
that passed the quality control (Extended data 3d) were then corrected for technical batch 148 
effects (e.g. 10x run) using BBKNN. Unbiased clustering followed by a two-dimensional 149 
uniform manifold approximation and projection (UMAP) on the corrected data identified 13 150 
distinct clusters (Fig. 2a). Cluster assignments were independent of batch (Extended data 151 
3e) and donor (Extended data 3f) effects. The CD8+IL-7R+ and CD8+IL-7R+ groups 152 
associated with distinct sets of clusters (Fig. 2b). The number of cells within each cluster 153 
varied from 9,263 to 915 (Extended data 3g) and their expression of Il7r mRNA was 154 
confirmed (Extended data 4a). We assigned clusters to cell types based on differential 155 
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analysis comparing expression values among cells from a given cluster to all other cells 156 
(Supplementary Table 3). All clusters expressed transcripts for Cd3e and Cd8, but not Cd4 157 
(Fig. 2c). We could identify clusters of TN cells (expressing Cd27, Ccr7, Sell or Cd28) and 158 
effector T cells (expressing Klrg1, Prf1 or Gzmb) (Fig. 2c). Based on this expression profile, 159 
clusters C0, C4 and C8 were defined as CD8+ TN cells, and C1, C2 and C6 as CD8+ TEMRA 160 
cells (Fig. 3a). A second round of clustering performed on these six clusters confirmed the 161 
distinct transcriptomic profiles of the CD8+ TN and CD8+ TEMRA compartments (Fig. 3b, 162 
Extended data 4b) and confirmed the enrichment of the CD8+TEMRA compartment within the 163 
CD8+IL-7R- cells (Extended data 4c). CD8+ TN cells were characterized by the expression of 164 
Cd27, Cd28, Ccr7 and Sell, while CD8+ TEMRA cells showed an upregulation of Klrg1, Prf1 or 165 
Gzmb relative to the clusters of CD8+ TN cells (Extended data 4d). 166 
The expression of 15 NK-associated genes, including Fcgr3a (encoding the Fcγ receptor 167 
CD16), the NK-related receptors Fcrl6, Klrc1 and -2, Klrg1, and Tyrobp (Fig. 3c) was used to 168 
define an “NK score”. This confirmed that CD8+ TEMRA cells become NK-like compared to 169 
CD8+ TN cells (Fig. 3d; Supplementary table 4). Similarly, we used expression of 170 
senescence-related genes, such as B3gat1 (encoding the enzyme that creates the CD57 171 
epitope), the cell cycle regulators Cdkn1a and Cdkn2a, and sMAC components such as 172 
Sesn2 and Mapk1 to create a “senescence score” to determine that CD8+ TEMRA are 173 
senescent compared to CD8+ TN cells (Fig. 3e,f, Supplementary table 4). Although 174 
expression of LCK, PLC-γ1 and LAT proteins was decreased in CD27-CD28-CD8+ T cells 175 
compared to TN CD8+ cells (Fig. 1e), the mRNA for these TCR signalling components was 176 
similar in TEMRA and TN CD8+ cells analysed by scRNA-seq (not shown), suggesting their 177 
expression might be regulated by post-translational modification in CD27-CD28-CD8+ T cells. 178 
These observations suggested that TEMRA CD8+ T cells had characteristics of cellular 179 
senescence and expressed a range of NKRs, NK adaptors and cytotoxic mediators.  180 
NKG2D and DAP12 induce cytotoxicity in senescent T cells  181 
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We next investigated whether CD27-CD28-CD8+ T cells had NK cell-like functions 182 
independently of TCR-MHC interactions. Based on the expression of the degranulation 183 
marker CD107a21, CD27-CD28-CD8+ T cells killed K562 cells, an MHC class I-deficient 184 
tumour cell line, with the same efficiency as NK cells (Fig. 4a). These data were confirmed 185 
using a calcein-release assay (Extended data 5a,b). To address whether NKG2D mediated 186 
the cytotoxic activity of CD27-CD28-CD8+ T cells, we knocked down NKG2D in CD28-CD8+ T 187 
cells with a small interfering RNA (siRNA) specific for NKG2D (siNKG2D CD8+T cells) and 188 
assessed their ability to kill MHC class I-deficient C1R cells transfected with the NKG2D 189 
ligand MICA*008 (C1R-MICA cells) when co-cultured for 6 hours (Extended data 5c,d). 190 
CD28-CD8+T cells transfected with scrambled siRNA (siCtrl) showed increased 191 
degranulation, measured by CD107a exposure, towards C1R-MICA compared to C1R cells, 192 
while the cytotoxicity of siNKG2D CD8+ T cells towards the C1R-MICA cells was inhibited 193 
compared to siCtrl (Fig. 4b), indicating that CD28-CD8+ T cells could kill target cells in a 194 
manner dependent on NKG2D. 195 
Expression of NKG2D on the cell surface requires its association with adaptor proteins that 196 
stabilise the immunoreceptor complex and provide it with signalling activity22. NKG2D 197 
associates with the adaptor molecules DAP10 and DAP12. DAP10 contains an YxxM-motif 198 
that activates PI3K23,24, while DAP12 has an ITAM-motif that can recruit and activate ZAP70-199 
Syk triggering cytokine release and cytotoxicity25-27. In human CD8+ T cells, NKG2D is 200 
predominantly associated with DAP1023,27 (Extended data 5e), which allows it to act as a 201 
co-stimulatory signal for the TCR. Immunoblot analysis (Fig. 4c) and intracellular flow 202 
cytometry (Fig. 4d) indicated increased expression of DAP12 in CD27-CD28-CD8+ T cells 203 
compared to TN CD8+ cells, corresponding to the transcriptomic data indicating that Tyrobp 204 
(which encodes DAP12) was strongly induced in TEMRA CD8+ T cells compared to TN CD8+ 205 
cells (Fig. 1c, 3c). To investigate whether the killing activity of CD27-CD28-CD8+ T cells was 206 
mediated by DAP12 association with NKG2D we immunoprecipitated NKG2D from 207 
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CD28+CD8+ or CD28-CD8+ T cells isolated from peripheral blood of healthy donors. DAP12 208 
associated with NKG2D only in the CD28-CD8+ T cells (Fig. 4e). 209 
We next investigated whether ligation of NKG2D induced the phosphorylation of ZAP70-Syk 210 
in CD27-CD28-CD8+ T cells. CD3 ligation with an anti-CD3 monoclonal antibody (mAb) 211 
induced the phosphorylation of ZAP70-Syk, as expected, while using an anti-NKG2D mAb 212 
alone induced more p-ZAP70 and p-Syk compared to anti-CD3 alone (Fig. 4f), indicating 213 
that CD27-CD28-CD8+ T cells can be activated by both the TCR and NKG2D, but show an 214 
increased propensity to respond to the latter. Anti-NKG2D stimulation alone was sufficient to 215 
induce expression of granzyme B and secretion of IFN-γ in CD27-CD28-CD8+ T cells (Fig. 216 
4g). siRNA-mediated silencing of DAP12 in CD28-CD8+ T cells impaired the cytolytic 217 
degranulation of CD28-CD8+ T cells towards C1R-MICA cells compared to scrambled siRNA 218 
control-transfected CD28-CD8+ T cells (Fig. 4h). Thus, DAP12 expression was upregulated 219 
in CD28-CD8+ T cells and was necessary and sufficient to mediate NKG2D-dependent 220 
cytotoxicity.  221 
Sestrins block TCR signalling but increase NKR in CD8+ T cells 222 
CD27-CD28-CD8+ T cells have reduced proliferative activity after TCR stimulation4,5,7. We 223 
investigated whether reduced expression of the components of the CD3-TCR complex 224 
compromised the efficiency of proximal TCR signaling. Phospho-flow cytometry indicated 225 
impaired phosphorylation of CD3ζ after stimulation with CD3 antibodies in CD27-CD28-CD8+ 226 
compared to CD27+CD28+CD8+ T cells (Fig. 5a). Although the expression of total Zap70 227 
was increased in CD28-CD27-CD8+ T cells (Fig. 1e), its phosphorylation was impaired in 228 
these cells compared to CD28+CD27+CD8+ T cells following CD3 activation (Fig. 5b).  229 
The stress-sensing proteins sestrins induce characteristics of senescence in CD4+ T cell by 230 
forming a complex with the kinase AMPK and the MAP kinases that is inhibitory for signalling 231 
through the TCR7. Flow cytometry (Fig. 5c,d) and immunoblotting (Fig. 5e) indicated that 232 
peripheral blood CD27-CD28-CD8+ T cells exhibited increased expression of sestrin 1 and 233 
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sestrin 2 compared to CD27+CD28+CD8+ T cells. Sestrin 2 was upregulated in total CD8+ T 234 
cells from donors older than 65 years compared to those between 18-35 years (Extended 235 
data 5f). In addition, CD27-CD28-CD8+ T cells had increased amounts of activated Jnk MAP 236 
kinase (P-Jnk) compared to CD27+CD28+CD8+ T cells (Fig. 5e).  Immunoprecipitation 237 
experiments indicated that DAP12, sestrin 2 and Jnk were associated with NKG2D in CD27-238 
CD28-CD8+ T cells (Fig. 6a), while imaging cytometry indicated that sestrin 2, DAP12 and p-239 
Jnk co-localised in CD27-CD28-CD8+ but not CD8+ TN cells (Fig. 6b,c). These observations 240 
suggested that sestrin 2 associated with NKG2D-DAP12-Jnk in CD27-CD28-CD8+ cells. 241 
Next, we tested whether sestrins regulated the expression of NKG2D in human CD28-CD8+ 242 
T cells. Peripheral blood CD28-CD8+ T cells isolated from healthy donors were lentivirally 243 
transduced with shRNA against Sesn1, 2 and 3 (shSesn) had significantly reduced 244 
expression of DAP12 (Fig. 6d) and NKG2D compared to CD28-CD8+ T cells transduced with 245 
control vectors (Fig. 6e), indicating sestrins modulated the expression of NKG2D in these 246 
cells. siRNA-mediated (Fig. 6f) or inhibition of Jnk with the small molecule inhibitor SP-247 
600125 (Fig. 6g) also reduced the expression of NKG2D, while increasing the frequency of 248 
CD28 expression and restoring proximal TCR signalling following anti-CD3 mAb ligation in 249 
CD28-CD8+ T cells compared to untreated controls (Fig. 6f,g). This indicated a reconstitution 250 
of T cell related functions, implying sestrins may act through Jnk to induce expression of 251 
NKG2D expression in CD28-CD8+ T cells. 252 
 253 
YFV induces the upregulation of NKR on CD8+ T cells 254 
Next we tested if the upregulation of NKRs by CD8+ T cells occurred exclusively as a result 255 
of cellular senescence or if NKRs were expressed on less-differentiated subsets of CD8+ T 256 
cells in response to antigenic stimulation and the expression was maintained as cells 257 
differentiated towards senescence. Using publicly available RNA-seq gene expression data 258 
generated in a cohort of 12 individuals vaccinated against yellow fever28. We compared TE 259 
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CD8+ T cells, defined as YFV-tet+ cells at day 14 post-vaccine, and CD8+ TM cells, defined 260 
as YFV-tet+ cells 4-13 years post-vaccine and these populations were compared to YFV-tet- 261 
CD8+ TN cells. Cytotoxic mediators such as Fasl, Prf1, Gzma and Gzmb were highly 262 
expressed in TE and TM compared to TN CD8+ T cells (Extended data 6). Additionally, there 263 
was a significant upregulation of multiple NKRs, including many of the Kir, Fcgr3a, Cd57 and 264 
Klrc1 on TE and TM compared to TN CD8+ T cells , as well as chemokine receptors (S1pr5, 265 
Cmklr1 and Cx3cr1) and NK adaptor proteins such as Tyrobp (Extended data 6). The 266 
upregulation of these molecules occurred on YFV-tet+ TE CD8+ T cells during the effector 267 
phase of the response and was maintained in long-lived YFV-tet+ TM (Extended data 6). 268 
Based on published data, YFV‐tet+ TM cells lack markers of senescence like CD57, are 269 
CD27+CD28+ and are polyfunctional with regard to cytokine secretion29. Unlike the CD8+ 270 
TEMRA cells, YFV‐tet+ CD8+ TM cells exhibit proliferative potential in vitro, suggesting that they 271 
were not terminally differentiated29. YFV-tet+ TE and TM CD8+ T cells showed slight 272 
downregulation of the TCR signalosome (Lat, Plcg1, Zap70) compared to TN cells 273 
(Extended data 6).  Of note, sestrin 2 was upregulated in the YFV-tet+ TE and TM compared 274 
to TN CD8+ T cells (Extended data 6). This analysis indicated that the expression of NKR on 275 
CD8+ T cells was not limited to senescent CD27-CD28-CD8 T cells but was also a feature of 276 
YFV-tet+ TE and TM CD8+ T cells after activation in vivo. 277 
 278 
Sestrins regulate the function of CD8+ T cells in vivo 279 
Sestrins regulate the decreased function of CD4+ T cells in aged mice and humans7. We 280 
next investigated if sestrins directly regulated the expression of NKRs in CD8+ T cells in 281 
young (~6 weeks) and old (~18 months) wild-type mice and old (~18 months) Sesn1-/- and 282 
Sesn2-/- mice. Mice were vaccinated subcutaneously against methylated BSA (mBSA) and 283 
re-challenged with mBSA in the footpad two weeks later to induce a delayed-type 284 
hypersensitivity (DTH) response as an index of successful immune induction. All mice 285 
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mounted a DTH response to the re-challenge, but the DTH response in old wild-type, Sesn1-286 
/- and Sesn2-/- mice resulted in increased footpad swelling compared to young wild-type mice 287 
(Fig. 7a). The response resolved more slowly in old wild-type compared to young wild-type 288 
mice, while old Sesn1-/- and Sesn2-/- mice resolved faster than old wild-type mice (Fig. 7a,b). 289 
Spleen weights were equivalent in all groups post-mBSA challenge (Extended data 7a). 290 
There were no changes in the proportions of splenic NK cells, iNKT cells, CD4+ T cells and 291 
CD8+ T cells in all old and young mice following the DTH response (Extended data 7b,c). 292 
However, CD44+CD62L-CD8+ TEFF cells expanded, while CD44-CD62L+CD8+ TN cells 293 
decreased in old wild-type mice, but not in old Sesn1-/- and Sesn2-/- mice, compared to 294 
young wild-type mice (Extended data 7d,e). 295 
Expression of NKG2D and DAP12, as well as NKG2A, NKG2C, NKG2E and Ly49 was 296 
higher on the CD8+ T cells from the old wild-type mice compared to the young wild-type 297 
mice, whereas their expression was lower in both old Sesn1-/- and Sesn2-/- mice compared to 298 
old wild-type mice (Fig. 7c-e and Extended data Fig. 7f), suggesting the expression of 299 
these receptors was modulated by sestrins. Importantly, the expression of NKG2D, as well 300 
as NKG2A, NKG2C, NKG2E on CD3-TCRβ-NK1.1+ NK cells or TCRβ+CD1d-tet+ iNKT cells 301 
was similar in young wild-type, old wild-type and both Sesn1-/- and Sesn2-/- mice (Fig. 7f,g), 302 
indicating that sestrins uniquely regulated the expression of NKRs in CD8+ T cells. To 303 
examine the effect of sestrin deficiency on the cytotoxic function of CD8+ T cells in vivo, 24-304 
month old  wild-type mice and 24-month old Sesn1-/-Sesn2-/-Sesn3+/- mice were NK-depleted 305 
with intra-peritoneal anti-NK1.1 treatment prior to intra-venous injection of equal numbers of 306 
5tgm1 myeloma cells expressing Rae-1, the mouse equivalent of MICA/B, and Rae-1- 307 
splenocytes. Six hours post-transfer of target cells, more Rae-1+ 5TGM1 cells were detected 308 
in the spleens of Sesn1-/-Sesn2-/-Sesn3+/- mice compared to wild-type mice (Fig. 7h). This 309 
resulted from decreased specific lysis of Rae-1+ 5TGM1 target cells in Sesn1-/-Sesn2-/-310 
Sesn3+/- mice compared to wild-type mice (Fig. 7i). These observations indicated that the 311 
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sestrins regulated the expression of NKG2D and DAP12 and confer NK cell-like cytotoxic 312 
activity to CD8+ T cells of old animals in vivo. 313 
 314 
Discussion 315 
Here we provide phenotypic, functional and mechanistic data to support the idea that as 316 
CD8+ T cells differentiated towards senescence they lose the expression of co-stimulatory 317 
molecules e.g. CD28 and CD27 and they downregulate TCR signalling molecules such as 318 
Lck and LAT concomitantly with upregulating the expression of NKR such as NKG2D, 319 
NKG2A and CD16. The CD28-CD27- CD8+ T cells also acquire a senescent phenotype 320 
compared to CD28+ CD27+CD8+ T cells. This transition for TCR to NKR expression during 321 
CD8+ T cell differentiation was associated with the acquisition of the ability to kill tumour cells 322 
both in vitro and in vivo by an NKR dependent process. Furthermore, the switch between 323 
TCR and NKR expression was regulated by the sestrins.  324 
 325 
Other studies indicate that altered TCR signalling pathways are associated with the 326 
development of unconventional functions that are not restricted to the TCR-MHC 327 
interactions30,31. The suppression of TCR signalling along with an acquired responsiveness 328 
to innate stimuli was proposed to be a characteristic that defines innate-like T cells32. We 329 
found that the TCR to NKR switch was dependent on the kinase Jnk in CD8+ and CD4+ T 330 
cells7, but the mechanism by which sestrins modulate this transition remains unclear. 331 
Experiments in sestrin-deficient mice indicated that these molecules did not regulate the 332 
expression of NKRs in NK cells or iNKT cells and it remains unclear if sestrins may regulate 333 
the function of other types of innate-like T cells e.g. γδ T cells.  334 
 335 
This reprogramming of senescent CD8+ T cells would repurpose them to exhibit broad NK-336 
like activity. This could be particularly relevant for T cells specific for persistent pathogens, 337 
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such as cytomegalovirus (CMV) and Epstein-Barr virus (EBV) that accumulate during 338 
ageing33-35. Our data suggest that in addition to their role in maintaining long-term specific 339 
immunity against these viruses, these cells may also recognize a cells infected by different 340 
viruses and also tumour cells via an NK-like function, in an antigen-independent manner 341 
thus enabling them to exhibit broad protective function.  342 
 343 
While the long-term blockade of sestrins may be dangerous, as it would enhance the 344 
proliferation of senescent-like T cells that harbour DNA damage, temporary blockade could 345 
be exploited to increase the number of antigen-specific T cell numbers to boost vaccine 346 
responsiveness in aged individuals7. In this context, it is important to know when the 347 
expression of sestrins and NKRs occurs on T cells after vaccination. Gene expression 348 
studies in YFV-specific CD8+ T cells after vaccination of previously non-immunized 349 
individuals found that both NKR and sestrin expression were upregulated in the effector 350 
phase of the response (weeks) and maintained in the TM cells for years28,29. This indicates 351 
that sestrins are induced in effector and memory CD8+ T cells during primary vaccination 352 
responses and not only on senescent CD8+ T cells. It would be important to determine how 353 
these molecules are expressed during a secondary response and during vaccination of older 354 
humans.  355 
 356 
These findings raise questions about the biological significance of such changes and the 357 
possible advantage of generating T cells with NK cell-like characteristics. The accumulation 358 
of TEMRA CD8+ T cells was reported to be a predictor of successful ageing8. One reason for 359 
this may be the acquisition of NKRs by TEMRA CD8+ T cells may allow them to broaden their 360 
capacity for immune surveillance by utilising different recognition systems, which may 361 
compensate in part for decreased output of TN in older subjects36. Given the increased 362 
burden of tumours and infections with age, the expansion of NK-like CD8+ T cells would be 363 
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an advantageous adaptation that enable the recognition of many different tumour cell types. 364 
Furthermore, non-lymphoid senescent cells are pro-inflammatory and increase in number in 365 
many organs during ageing37,38. The removal of these senescent cells from tissues has been 366 
shown to enhance organ function and retard age-related functional decline39,40.  Since NK 367 
and CD8+ T cells can also recognize and kill senescent cells via NKG2D mediated 368 
mechanisms9, 10,41 another role of NKR expressing senescent CD8+ T cells may be to 369 
participate in the surveillance and elimination of senescent tissue cells in vivo. This study 370 
highlights the central role of the sestrins in functional fate decisions in T cells. It will be 371 
important to identify if these molecules also have similar roles in other cell types.    372 
 373 
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Materials and Methods 409 
Study design 410 
The study protocol was approved by the Ethical Committee of the Royal Free and University 411 
College London Medical School (Research Ethics number: 11/0473). Written informed 412 
consent was obtained from all study participants. Donors did not have any co-morbidity, 413 
were not on any immunosuppressive drugs, and retained physical mobility and lifestyle 414 
independence. For analyses involving the CD8+ T cell, IL-7R+/IL-7R- single cell dataset 415 
studies were conducted following approval by the Institutional Review Board (IRB) of the 416 
University of Connecticut Health Center (IRB 14-194J-3). After receiving informed consent, 417 
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blood samples were obtained from 6 healthy old (>65 year old) research volunteers residing 418 
in the Greater Hartford, CT, region using services of the University of Connecticut Center on 419 
Aging Recruitment and Community Outreach Research Core and following previously 420 
published screening criteria (PMID:28904110). 421 
 422 
Cell isolation and transfection  423 
Peripheral blood mononuclear cells (PBMC) were isolated by density gradient (Ficoll–424 
Hypaque, Amersham Biosciences, UK) from heparinized blood of healthy donors (n = 22, 425 
26-83 years). Untouched NK and CD8+ T cells were freshly isolated by magnetic activated 426 
cell sorting (MACS, Miltenyi Biotec, UK) using a negative selection procedure. For 427 
microarray analysis, high-purity CD8+ T cell subsets were sorted on the basis of CD27 and 428 
CD45RA expression42, using a FACSAria (BD Biosciences, UK) flow cytometer. For 429 
functional assays, CD8+ T cell subsets were freshly isolated according to CD27/CD28 430 
expression by magnetic activated cell sorting (MACS, Miltenyi Biotec, UK), which identified 431 
analogous subsets but provided higher yields of viable cells (> 95% purity) as previously 432 
described5,7. Double negative cells were obtained by complete negative isolation. We found 433 
that <1% of cells within these isolated populations expressed iNKT markers. Mucosal 434 
associated invariant T cells (MAIT) cells express TCR Vα7.2 and these cells constitute ~5% 435 
of the peripheral CD8+ T cells pool in humans43. We found 4% (range 1-7.5%) of these cells 436 
in isolated CD28+ CD27+, 3% (range 1-6.4) in the isolated CD28-CD28+ and 2.9% (range 1-437 
4.9%) in the isolated CD28-CD27- CD8+ T cells populations. The results obtained are 438 
therefore unlikely to be due to contaminating iNKT or MAIT cells in our CD8+ T cells 439 
populations. 440 
Where indicated, freshly purified human CD8+ T cells were transfected with small interfering 441 
RNA (siRNA) for NKG2D (Santa Cruz Biotechnology, sc-42948) or DAP12 (sc-35172) by 442 
electroporation using the Amaxa Human NK Cell Nucleofector Kit and Nucleofector 443 
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technology (Lonza), according to the manufacturer’s instructions. A scrambled control siRNA 444 
(sc-37007; Santa Cruz) was used throughout. Efficiency of siRNA transfection was 445 
confirmed by measuring the expression of the protein of interest using flow cytometry, 36-48 446 
hours after transfection. 447 
Microarray data acquisition 448 
Cells purified by FACS were stimulated for 2 hours with 0.5 µg/ml plate-coated anti-CD3 449 
(OKT3) and 5 ng/ml rhIL-2 before RNA isolation using the ARCTURUS PicoPure Isolation 450 
Kit (ThermoFisher). The concentration of small quantities of RNA was determined using 451 
Nanodrop. Linear amplification of 10 ng of total RNA was performed using the Ovation Biotin 452 
RNA amplification and labelling system (NuGEN). Fragmented, labelled cDNA was 453 
hybridized to Affymetrix U133 plus 2 arrays. 454 
Single cell RNA sequencing 455 
Sample processing: all samples were processed within one hour from venipuncture. 456 
Cell Sorting: PBMCs were isolated from fresh whole blood using Ficoll-Paque Plus (GE) 457 
density gradient centrifugation. For cell sorting, we used fluorochrome-labeled antibodies 458 
specific for CD3 (UCHT1), CD27 (M-T271) (Biolegend), CD4 (RPA-T4), CD19 (HIB19), IgD 459 
(IA6-2), CD127 (HIL-7R-M21) (BD Biosciences), and CD8 (SCF121Thy2D3) (Beckman-460 
Coulter). CD8+IL7R+ (CD8+CD127+) and CD8+IL7R- (CD8+CD127-) T cells were sorted from 461 
the CD19-CD3+CD4- fraction. Cell sorting was performed using FACSAria Fusion (BD).  462 
Blood preparation for single cell RNA sequencing (scRNA-seq): PBMCs were thawed 463 
quickly at 37oC and transferred to DMEM supplemented with 10% FBS. Cells were spun 464 
down at 400 g, for 10 min. Cells were washed once with 1 x PBS supplemented with 0.04% 465 
BSA and finally re-suspended in 1 x PBS with 0.04% BSA. Viability was determined using 466 
trypan blue staining and measured on a Countess FLII and samples with <80% viability were 467 
discarded. 12,000 cells were loaded for capture onto the Chromium System using the v2 468 
single cell reagent kit (10X Genomics). Following capture and lysis, cDNA was synthesized 469 
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and amplified (12 cycles) as per manufacturer's protocol (10X Genomics). The amplified 470 
cDNA was used to construct an Illumina sequencing library and sequenced on a single lane 471 
of a HiSeq 4000. 472 
Single cell Raw data processing and data combination: Illumina basecall files (*.bcl) 473 
were converted to fastqs using cellranger v2.1.0, which uses bcl2fastq v2.17.1.14. FASTQ 474 
files were then aligned to hg19 genome and transcriptome using the cellranger v2.1.0 475 
pipeline, which generates a gene - cell expression matrix. The samples were merged 476 
together using cellranger aggr from cellranger, which aggregates outputs from multiple runs, 477 
normalizing them to the same sequencing depth (normalize=mapped) and then re-478 
computing the gene-barcode matrices and analysis on the combined data (See scripts here: 479 
https://github.com/dnehar/Temra-IL7R-Senescence).  480 
Scrublet for multiplet prediction and removal: Generally, we expected about 2 to 8% of 481 
the cells to be hybrid transcriptomes or multiplets, occurring when two or more cells are 482 
captured within the same microfluidic droplet and are tagged with the same barcode. Such 483 
artifactual multiplets can confound downstream analyses. We applied Scrublet44 python 484 
package to remove the putative multiplets. Scrublet assigns each measured transcriptome a 485 
‘multiplet score’, which indicates the probability of being a hybrid transcriptome. Multiplet 486 
scores were determined for each individual (using the raw data), and 0.7% - 10.7% highest 487 
scoring cells were tagged as multiplets after visual inspection of doublet score distributions 488 
and excluded from the further analysis.  489 
Single cell processing, clustering and cell type classification: The aggregated matrices 490 
were fed into the Python-based ScanPy45 workflow 491 
(https://scanpy.readthedocs.io/en/stable/), which includes preprocessing, visualization, 492 
clustering and differential expression testing. The pipeline we used was inspired by The 493 
Seurat46 R package workflow. 494 
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Quality control and cell-filtering: We applied the following filtering parameters: (i) all 495 
genes that were not detected in ≥ 3 cells were discarded, (ii) cells with less than 400 total 496 
unique transcripts were removed prior to downstream analysis, (iii) cells in which > 20% of 497 
the transcripts mapped to the mitochondrial genes were filtered out, as this can be a marker 498 
of poor-quality cells and (iv) cells displaying a unique gene counts > 2,500 genes were 499 
considered outliers and discarded. 500 
Data normalization: After discarding unwanted cells from the dataset, we normalized the 501 
data. Library-size normalization was performed based on gene expression for each barcode 502 
by scaling the total number of transcripts per cell to 10,000. We log-transformed the data 503 
and then regressed out using the total number of genes and the fraction of mitochondrial 504 
transcript content per cell. 1202 highly variable genes (HVG) were identified using 505 
filter_genes_dispersion scanpy function and used to perform the principal component 506 
analysis (PCA). 507 
Linear dimensional reduction using PCA and graph-based clustering: Dimensionality 508 
reduction was carried out in SCANPY via principal component analysis followed by Louvain 509 
clustering UMAP visualization using the top 40 significant components (PCs)47. 510 
Finding marker genes/evaluation of cluster identity: To annotate the cell type of each 511 
single cell transcriptome, we used both differential expression analysis between clusters and 512 
classification based on putative marker gene expression. We applied the 513 
‘tl.rank_genes_groups’ scanpy function to perform differential analyses, comparing each 514 
cluster to the rest of the cell using Wilcoxon test (Supplementary Table 3). We only 515 
considerate clusters that showed a distinct trancriptomic programs. 516 
Batch effect correction: We performed a batch (10X genomics batch) correction using 517 
BBKNN (https://github.com/Teichlab/bbknn)48. More details about the parameters used can 518 
be found as a Jupyter notebook here: https://github.com/dnehar/Temra-IL7R-Senescence. 519 
NK and Senescence scores:  520 
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Gene lists (Table S3) were used to score NK or senescence expression in naïve and 521 
Temras CD8 T cells. To do so, we calculated the mean expression for each cell, within each 522 
cluster using the h5ad object (adata), as follow:  523 
adata.obs['NK_score] = adata.X[:,NK_markers].mean(1). 524 
The scores were then plotted, as shown in Fig .3D.  525 
Lentiviral transduction 526 
Sestrin knockdown in human CD8+ T cells was achieved using a lentiviral transduction 527 
system as described previously9. 528 
The pHIV1-SIREN-GFP system used for knockdown of gene expression possesses a U6-529 
shRNA cassette to drive shRNA expression and a GFP reporter gene that is controlled by a 530 
PGK promoter5. The following siRNA sequences were used for gene knockdowns: 531 
CCTAAGGTTAAGTCGCCCTCG (shCTRL), CCAGGACCAATGGTAGACAAA (shSesn1), 532 
CCGAAGAATGTACAACCTCTT (shSesn2) and CAGTTCTCTAGTGTCAAAGTT (shSesn3). 533 
VSV-g pseudotyped lentiviral particles were produced, concentrated and titrated in HEK293 534 
cells as described9. 535 
Cells were cultured in RPMI-1640 medium supplemented with 10% heat-inactivated FCS, 536 
100 U/ml penicillin, 100 mg/ml streptomycin, 50 μg/ml gentamicin, 2 mM L-glutamine (all 537 
from Invitrogen) and 0.5 ng/ml anti-mycoplasma (Bio-Rad) at 37 °C in a humidified 5% CO2 538 
incubator. Purified human highly differentiated CD28−CD8+ T cells were activated in the 539 
presence of plate-bound anti-CD3 (purified OKT3, 0.5 μg/ml) plus rhIL-2 (R&D Systems, 10 540 
ng/ml), and then transduced with pHIV1-Siren lentiviral particles (multiplicity of infection 541 
(MOI) = 10) 72 h after activation. 542 
Flow cytometry and Phospho-flow 543 
Multi-parameter flow cytometry was used for phenotypic and functional analyses of PBMC. 544 
For analysis of surface markers, staining was performed at 4°C for 30 min in the presence of 545 
saturating concentrations of antibodies (listed in Supplementary table 5) and a live/dead 546 
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fixable Near-Infrared stain (Thermo Scientific, L10119). For intracellular analysis of cytokine 547 
secretion, cytotoxic granule expression, and sestrin 1, sestrin 2, DAP12, and DAP10 548 
expression, cells were fixed and permeabilized with the Fix & Perm® Kit (Invitrogen, Life 549 
Technologies, UK), before incubation with indicated antibodies or the respective isotype 550 
controls. For imaging cytometry, samples were acquired on an Amnis ImageStreamX Mk2 551 
using INSPIRE software, magnification 60X. Data were analysed using IDEAS v6.2 software 552 
(Amnis). Co-localization of signals was determined on a single cell basis using bright detail 553 
similarity (BDS) score analysis. Co-localization was considered with BDS ≥ 2.0. 554 
For Phospho-Flow cytometry, after staining for surface markers, CD8+ T cells were 555 
stimulated with anti-CD3 (purified OKT3, 10 μg/mL) for 30 minutes on ice, followed by 556 
crosslinking with goat anti–mouse IgG antibody during 30 minutes on ice. Cells were then 557 
transferred to an incubator at 37°C, and stimulation was terminated after 10 minutes, with 558 
immediate fixation with Cytofix Buffer (PBS containing 4% paraformaldehyde, BD 559 
Biosciences) followed by permeabilization with ice-cold Perm Buffer III (PBS containing 90% 560 
methanol, BD Biosciences) and staining with antibodies for phospho-proteins (listed in Table 561 
2) for 30 minutes at room temperature. Samples were acquired on a LSR II flow cytometer 562 
(BD Biosciences) and analysed using FlowJo software (TreeStar). 563 
Cytotoxic assays - CD107a degranulation assay 564 
Freshly isolated NK and CD8+ T cell subsets were incubated at 37°C for 6 h with K562 or 565 
C1R-MICA/C1R cells, at a fixed effector to target (E:T) ratio of 2:1, in the presence of APC-566 
conjugated CD107a antibody (BD Biosciences), as previously described68. Brefeldin A 567 
(1μg/ml; Sigma-Aldrich) and Monensin (1 μg/ml; Sigma-Aldrich) were added in the final 5h-568 
incubation period. Effector cells incubated alone in the presence phorbol-12-myristate-13-569 
acetate (PMA, 50 ng/ml, Sigma-Aldrich) with ionomycin, (250 ng/ml, Sigma-Aldrich) were 570 
used as positive control whereas medium alone served as unstimulated (US) control. After 571 
incubation, cells were stained for surface markers for 30 min on ice, followed by intracellular 572 
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detection of cytokines (TNF-α and IFN-γ) and CD107a expression and analysed by flow 573 
cytometry. 574 
Cell lines 575 
K562 (human erythroleukemic) cell line was purchased from the European Collection of Cell 576 
cultures (ECCAC, UK) and cultured in 25 cm2 flasks (Nunc) in complete RPMI-1640. B-577 
lymphoblastoid cell lines, C1R and C1R transfected with MICA*008 (C1RMICA) were kindly 578 
provided by Professor Antoine Toubert (INSERM UMR1160, Paris) and maintained in 579 
complete RPMI-1640 in the presence of the aminoglycoside antibiotic G-418 (Sigma, 580 
G8168) for selection of transfected cells49. 581 
Immunoblotting 582 
Human CD8+ T cell subsets purified using immunomagnetic separation (MACS) according to 583 
CD27/CD28 expression were stimulated with anti-CD3 (purified OKT3, 10 μg/mL) or anti-584 
NKG2D (1D11, 10 μg/mL) before lysis. Cells were normalized by equal cell number, 585 
harvested and lysed in ice-cold Radio-Immunoprecipitation Assay (RIPA) buffer (Sigma-586 
Aldrich, UK), supplemented with protease and phosphatase inhibitors (GE Healthcare, 587 
Amersham, UK), during 30 minutes on ice. Cell lysates were processed for immunoblot 588 
analysis as described6.  589 
Immunoprecipitation 590 
Human CD8+ T cells were separated into CD28+/CD28- fractions (to obtain sufficient number 591 
of cells for analysis) and stimulated with anti-NKG2D (1D11, 10 μg/mL) or isotype control, for 592 
30 minutes at 4 °C. Lysates from 1x107 cells were prepared with ice-cold HNGT buffer (50 593 
mM HEPES, pH 7.5, 150 mM EDTA, 10 mM sodium pyrophosphate, 100 mM sodium 594 
orthovanadate, 100 mM sodium fluoride, 10 mg/ml aprotinin, 10 mg/ml leupeptin and 1 mM 595 
phenylmethylsulfonyl fluoride), for 30 minutes on ice. Cell lysates were incubated overnight 596 
at 4°C with anti-NKG2D antibody (clone 5C6, Santa Cruz) or control antibody, followed by 597 
precipitation with 10 μL of pre-washed protein A/G agarose beads (sc-2003, Santa Cruz) for 598 
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3 h at 4°C on a rotary shaker. After extensive washing in HGNT buffer, supernatants were 599 
recovered and processed for immunoblot analysis, as described above. Co- 600 
Immunoprecipitated proteins were detected after incubation with primary antibodies followed 601 
by incubation with mouse anti-rabbit IgG (conformation-specific antibody; L27A9; Cell 602 
Signaling) or mouse anti-rabbit IgG light chain (L57A3; Cell Signaling) and by a secondary 603 
anti-mouse IgG antibody (7076; Cell Signaling). 604 
Mice 605 
Sesn1-/- and Sesn2-/- mice were described previously7. The mouse ageing study was 606 
performed at the University of Michigan, where the animal procedures were approved by the 607 
Institutional Animal Care & Use Committee and overseen by the Unit for Laboratory Animal 608 
Medicine. All mice were rested for at least 10 days before being used for in vivo studies. 609 
Animals were housed under standard conditions, maintained in a 12 h/12 h light/dark cycle 610 
at 22 oC ± 1 oC and given food and tap water ad libitum in accordance with United Kingdom 611 
Home Office regulations (PPL-P69E3D849) and the NIH guideline. 612 
Murine delayed type hypersensitivity model 613 
Knockout and age-matched (18-month-old) C57BL66J WT control mice were imported from 614 
the University of Michigan. Young (~6 weeks) WT mice were purchased separately from 615 
Charles River. All mice were male. The methylated BSA (mBSA) delayed type 616 
hypersensitivity model was performed as described previously50. Mice were sensitized at the 617 
base of the tail with a 50 µl injection of mBSA in Freund’s complete adjuvant (20 mg/ml 618 
solution of mBSA in saline emulsified with an equal volume of Freund’s adjuvant containing 619 
4 mg/ml Mycobacterium tuberculosis H37Ra, Sigma Aldrich). An immune response was 620 
evoked 14 days later by subplantar challenge with 50 µl of mBSA in saline (1 mg/ml). The 621 
contralateral paw received a saline-only injection and served as a control. The immune 622 
response is reported as the difference in paw swelling between left and right paws as 623 
determined using callipers (POCO2, Kroeplin). Mice were sacrificed 7 days post-challenge, 624 
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according to Schedule 1, using an increasing concentration of CO2. Death was confirmed by 625 
cervical dislocation. Spleens and inguinal lymph nodes were obtained, weighed and 626 
dispersed through a 70 µm followed by a 35 µm sterile cell sieve (Becton Dickinson) to yield 627 
single cell suspensions. Cell numbers were enumerated by haemocytometer and up to 106 628 
cells were used for polychromatic flow cytometry. 629 
In vivo cytotoxicity 630 
24-month-old knockout (Sesn1-/-Sesn2-/-Sesn3+/-) males were imported from the University of 631 
Michigan. Age-matched wild type female C57Bl/6J mice were purchased from Envigo. 632 
Natural killer cells were depleted by intraperitoneal injection of 100 μg anti-NK1.1 antibody 633 
(PK136, BioXCell) 24 hours before cell challenge. The high Rae-1 expressing myeloma cell 634 
line 5TGM was labeled with 5 μM CFSE, while splenocytes stained with 0.5 μM were used 635 
as Rae-1- controls. Both cell types were mixed at equal ratios and 2x107 were co-injected i.v. 636 
Mice were left for 6 hours before being sacrificed. As a measure of Rae-1 directed killing, the 637 
ratio of CFSEhi compared to CFSElo was used to determine Rae-1+ cell retrieval and specific 638 
lysis. 639 
Statistical analysis 640 
Statistical analysis was performed using GraphPad Prism version 6.00. Tests were used to 641 
determine data distribution and depending on the normality of the data, comparisons were 642 
performed using the Student t test (for two groups, parametric) or the non-parametric Mann–643 
Whitney U test (for two groups, unpaired) and the Wilcoxon signed rank test (for two groups, 644 
paired) with two-tailed P values unless otherwise stated. When comparing more than two 645 
groups, we used one-way ANOVA (parametric, > 2 groups, unpaired), repeated measures 646 
ANOVA (parametric, > 2 groups, paired), Kruskal–Wallis (non-parametric, > 2 groups, 647 
unpaired) or Friedman (non-parametric, > 2 groups, paired) tests with post-correction for 648 
multiple comparisons, as appropriate. The two-way ANOVA test was used to compare the 649 
effects of two independent variables between groups. Linear regression analysis was 650 
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performed to generate lines of best fit and correlations between variables were analysed 651 
using Pearson´s or Spearman’s rank correlation coefficient (r). Differences were considered 652 
significant when p <0.05 (*), p <0.01 (**), p <0.001(***) and p <0.0001 (****). Data are 653 
presented as means ± standard error of the mean (SEM) unless otherwise stated. 654 
Data and materials availability 655 
The data that support the findings of this study are available from the corresponding author 656 
upon request. The complete microarray dataset is available online from the NCBI Gene 657 
Expression Omnibus public repository (GEO accession number GSE98640). 658 
The single cell RNA-seq data are available on EGA (Accession number TBC). 659 
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 786 
Figure legends 787 
Fig. 1: Transcriptional signature of human CD8+ T cell subsets 788 
a) Representative image of CD8+ T cells gated on CD27+CD45RA+ TN cell, CD27+CD45RA-789 
TCM cells, CD27-CD45RA-TEM cells, and CD27-CD45RA+TEMRA cells isolated from the PBMCs 790 
from 6 healthy donors. Numbers in gates represent percentages of cells in each subset from 791 
a representative donor. Similar results were obtained in other experiments. b) Heat map of 792 
gene expression of Affymetrix U133 plus 2 microarrays of sorted TN and TEMRA CD8+ T cell 793 
subsets, showing downregulated (in yellow) and upregulated genes (in blue). c) The relative 794 
fold-change (log10) of differentially expressed genes of interest in TCM, TEM and TEMRA CD8+ T 795 
cell subsets compared to TN CD8+ T cells. The list of genes of interest is shown in 796 
Supplementary table 2 and the complete list of differentially expressed genes from the 797 
whole-transcriptome analysis (≥2-fold change, p<0.05, FDR<0.05%) is available in 798 
Supplementary table 1. d) NKR expression TN, TCM, TEM, and TEMRA CD8+ T cells assessed 799 
by flow cytometry on PBMCs from 22 healthy donors (median age = 52, range 25-83). e) 800 
Representative immunoblots of proximal TCR components Lck, PLCγ1, LAT and Zap70 on 801 
CD27+CD28+, CD27+CD28- and CD27-CD28- CD8+ T cells freshly isolated from PBMCs 802 
using magnetic activated cell. Similar data were obtained in 4 independent experiments. 803 
Summary data (n = 4) of Lck, Zap70, PLCγ1 and LAT expression normalized to the loading 804 
control (GAPDH) and presented relative to the basal expression in CD27+28+CD8+ cells set 805 
to 1. d) Two-way ANOVA with Dunnett’s post-test correction and e) one-way ANOVA with 806 
Tukey’s correction (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). 807 
Fig. 2: Single cell RNA-seq (scRNA-seq) of TN and TEMRA CD8+ T cells 808 
a) UMAP plot representing the putative identity of each CD8+ T cell cluster. Each colour 809 
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represents a cluster. b) UMAP plot representing clustering of IL7-R+ (in green) and IL7-R- (in 810 
purple) CD8+ T cells as identified during sorting. c) UMAP plots representing expression 811 
values of selected genes. Other aliases or CD numbers of proteins encoded by the listed 812 
genes are shown in brackets. 813 
Fig. 3: NK and senescence markers within TN and TEMRA 814 
a) Highlighted clusters were considered as TN (C0, C4 and C8) and TEMRA (C1, C2 and C6) 815 
compartments. b) A second round of clustering on the selected groups (n = 39,634 cells) 816 
was performed. UMAP plots representing the expression values of c) NK and e) 817 
senescence-associated genes are shown. Other aliases or CD numbers of some gene 818 
products are shown in brackets. d) NK and f) senescence scores were calculated based on 819 
the average normalized expression of each gene across TN and TEMRA compartments (gene 820 
lists in Supplementary table 4). 821 
Fig. 4: NKG2D-DAP12 complex mediates NK cytotoxicity in CD27-CD28-CD8+ T cells 822 
a) Cell-surface expression of CD107a detected by flow cytometry was used as a proxy of 823 
cytotoxic activity after 6 hour incubation with MHCI-deficient K562 cells (E:T ratio 2:1) of 824 
CD27+CD28+CD8+ (DP), CD27+CD28-CD8+ (SP), CD27-CD28-CD8+ (DN), and CD3-CD56+ 825 
NK cells isolated from healthy donors (median and range, n = 5). b) CD107a expression on 826 
CD28-CD8+ T cells transfected with NKG2D siRNA (siNKG2D) or control siRNA (siCtrl) and 827 
cultured with C1R-MICA or C1R (E:T ratio 2:1) for 6 hours (mean and s.e.m., n = 4). c) 828 
Immunoblots (representative of five independent experiments with similar results) and d) 829 
flow cytometry (means and s.e.m., n = 12) showing DAP12 expression on DP, SP, DN CD8+ 830 
T, and NK cells. g) Representative immunoblot of DAP12 from lysed CD28+CD8+ and CD28-831 
CD8+ T cells co-immunoprecipitated with anti-NKG2D. Detection of light-chain IgG (IgGL) 832 
served as a loading control. Whole-cell lysate immunoblot shown as a control. 833 
Representative of two independent experiments. f) Phosphorylation of 834 
Zap70(Tyr319)/Syk(Tyr352) in freshly isolated CD27-28- CD8+ T cells after anti-CD3 (OKT3, 835 
10 μg/mL) and/or anti-NKG2D (1D11, 5 μg/mL) stimulation. Numbers indicate relative 836 
expression normalized to total Zap70. Representative of 2 experiments. g) Granzyme B 837 
expression (left) and IFN-γ secretion (right) in DP, SP and DN CD8+ T cells after stimulation 838 
with anti-NKG2D (5 μg/mL, means and s.e.m., n = 15 donors). h) CD107a was assessed by 839 
flow cytometry on human CD28-CD8+ T cells, transfected with DAP12 siRNA (siDAP12) or 840 
control siRNA (siCtrl) cultured with C1R-MICA*008 or C1R cells for 6 hours (E:T ratio 2:1; 841 
means and s.e.m., n = 4). Statistical significance determined with Kruskal-Wallis test in a) 842 
Friedman test with Dunn´s correction in d), two-way ANOVA with Bonferroni correction in b, 843 
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j) and one-way ANOVA with Tukey’s in g) (*p <0.05, **p <0.01, ***p <0.001). 844 
Fig. 5: Sestrins and Jnk MAPK dampen TCR signalling in CD27-CD28-CD8+ T cells 845 
Proximal TCR signalling was assessed in CD27+CD28+CD8+ (DP), CD27+CD28-CD8+ (SP), 846 
and CD27-CD28-CD8+ (DN) T cells following TCR crosslinking with anti-CD3 (OKT3, 10 847 
μg/mL). Representative histograms and summary data (means and s.d., n = 8) of a) CD3ζ 848 
and b) Zap70/Syk phosphorylation are shown. Numbers on histograms represent the mean 849 
fluorescence intensity (MFI) for each subset. Light grey histograms represent unstimulated 850 
controls. Summary results presented as the MFI relative to that of DP CD8+ T cells, set to 1. 851 
Protein expression determined by flow cytometry of c) Sestrin 1 (Sesn1) and d) Sestrin 2 852 
(Sesn2) expression in DP, SP, and DN CD8+ T cell subsets (means and s.d., n = 10). e) 853 
Immunoblot image, representative of three independent experiments with similar results, of 854 
Sesn2 and phospho-Jnk (T183/Y185) on DP, SP, and DN CD8+ T cell subsets. Densitometry 855 
data from western blots for all donors is also shown (means and s.e.m., n = 3-4). Statistical 856 
significance determined with ANOVA with Friedman test and Dunn’s post-test correction in 857 
a-b), repeated measures one-way ANOVA with Tukey’s multiple comparisons test in c-e) (*p 858 
<0.05, **p <0.01, ***p <0.001, ****p <0.0001). 859 
Fig. 6: Sestrins regulate DAP12 and NKG2D expression in CD8+ T cells. 860 
a) Representative immunoblot of co-immunoprecipitation with anti-NKG2D of lysed CD28+ 861 
and CD28- CD8+ T cells showing DAP12, Sesn2 and P-Jnk (T183/Y185) expression. 862 
Detection of IgG light chain (IgGL) in immunoprecipitate blots (IP) served as loading control. 863 
Results are representative of 2 independent experiments. b) Representative images of 864 
imaging cytometry of Sesn2 (AF488, green), DAP12 (PE, red) and P-Jnk (T183/Y185, 865 
AF647, yellow) single stain controls as well as triple-stained CD27+CD28+ (DP) and CD27-866 
CD28- (DN) CD8+ T cells. Nuclei are stained with DAPI (blue). Scale bars – 7 µm. c) Bright 867 
Detail Similarity score to determine overlap of Sesn2 and DAP12 or P-Jnk in CD28+ and 868 
CD28- CD8+ T cells. Values exceeding 2 were considered to be overlapping. Data are 869 
normalized to the DP subset for each donor (means and s.d., n = 6). d-e) Isolated human 870 
CD8+CD28- T cells were transduced with control (shCtrl) or anti-sestrin (shSesn) vectors. d) 871 
Representative immunoblot for Sesn2 and DAP12 (representative of two experiments). e) 872 
Representative contour plots and summary data of NKG2D expression. Results are 873 
presented relative to cells transduced with shCtrl for each donor, set as 1 (means and s.d., n 874 
= 3 donors). f) Frequency of NKG2D and CD28 expressing cells after Jnk inhibition by 875 
siRNA in CD28-CD8+ T cells (means and s.d., n = 6 donors). P-Lck detection by flow 876 
cytometry of CD28-CD8+ T cells pre-treated with Jnk inhibitor (SP-600125, 10 µM) prior to 877 
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anti-CD3 stimulation (OKT3, 10 µg/ml; means and s.d., n = 8 donors). Two-tailed paired 878 
Student’s t tests in c,f-g) (*p <0.05, **p <0.01, ***p <0.001). 879 
Fig. 7: Sestrins induce an age-dependent NK phenotype in CD8+ T cells in vivo 880 
a) Time course of paw size (normalized to the contralateral, PBS control paw) following DTH 881 
challenge (at time = 0 h) and b) the overall response assessed as the integration of the time 882 
course data (means and s.d., n = 4 young wild-type (Y WT), 10 old wild-type (O WT), 5 old 883 
Sesn1-/- (O Sesn1-/-), and 4 old Sesn2-/- (O Sesn2-/-) mice. c) Representative pseudo-colour 884 
density plots for young wild-type (white), old wild-type (black), old Sesn1-/- (grey), and old 885 
Sesn2-/- (red) mice showing CD44 vs NKG2D expression. Frequencies of parent gates are 886 
shown in the top right-hand corner. The frequency of NKG2D expression in d) 887 
TCRβ+CD3+CD8+ T cells, f) NK1.1+NK cells, and g) TCRβ+CD3+CD1d-tet+ invariant NKT 888 
(iNKT) cells was assessed by flow cytometry (n = 3 mice per group). e) Representative 889 
histogram of DAP12 expression in TCRβ+CD3+CD8+ T cells with summary expression data 890 
(n = 3 per group, n = 1 young wild-type). h) Retrieval, 6 hours post-injection of CFSE-891 
labelled Rae-1+ 5TGM1 cells from NK-depleted (24h, anti-NK1.1 i.p.) old wild-type (WT) and 892 
old Sesn1-/-Sesn2-/-Sesn3-/+ (KO) mice (means and s.d., n = 3 mice per group). i) Specific 893 
lysis of Rae-1+ 5TGM1 cells in vivo (n = 3 mice per group). Statistical significance 894 
determined with one-way ANOVA with Tukey’s multiple comparisons test in b,d-g); two-895 
tailed unpaired Student’s t tests in h-i). (*p <0.05, **p <0.01, ***p <0.001, ****p <0.0001). 896 
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